Exploring the Efficacy of Bitter Apricot Seeds Compared to Laetrile (B17) in Cancer Treatment

A study conducted at the National Cancer Institute on breast tumors in mice compared the effectiveness of B17 to that of apricot seeds.

Surprisingly, the study revealed that apricot seeds had a notable impact in reversing breast tumors, while B17 did not yield similar results.

Dr. Livingston’s earlier assertion in 1979 suggested that the efficacy of apricot seeds could be attributed to abscisic acid. Subsequent research confirmed this hypothesis, revealing that abscisic acid, found abundantly in bitter apricot seeds, demonstrated efficacy against tumors.

Notably, abscisic acid follows the retinoic acid pathway, effectively targeting and destroying cancer stem cells (CSCs), which are the fundamental drivers of cancer growth and metastases.

Several substances have shown promise in inhibiting CSCs, including Ivermectin, Niclosamide and retinoic acid, along with certain teratogens known to be toxic to fetal cells. However, bitter apricot seeds appear to be particularly valuable in their ability to reverse tumors through this approach.

The growth pathway of CSCs, known as the hedgehog pathway, was discovered by Johns Hopkins University researchers.

They observed that a pregnant goat, upon consuming California Corn lily, experienced fetal abortion without harm to the mother goat. This observation led to the identification of the hedgehog pathway, a fetal pathway containing retroviruses that promote fetal growth but deactivate upon delivery. Remarkably, these retroviruses become reactivated in cancer cells, driving tumor growth.

Understanding and targeting CSCs, which originate from retroviruses in fetal cancer stem cells and become activated in tumors, is crucial for reversing cancer and achieving remission.

[Source: Int J Cancer. 2016 Apr 15;138(8):1947-58. doi: 10.1002/ijc.29935. Epub 2015 Dec 12.]